A founder cashing in and two finance directors buying and selling shares are among the most significant director deals of the past week.
The biggest deal comes from Paypoint (PAY) founder Tim Waktin-Rees and his spouse Eve Watkin-Ress, who sold just under 500,000 shares in a series of transactions, at an average price of 973p for a total amount of £4.9m.
Paypoint shares have had a bit of a volatile year with revenue going down and costs going up, but the roll-out of its new PayPoint One electronic point of sale system has been significantly ahead of expectations.
One director buying shares in their company is Glencore (GLEN) chief financial officer Steven Kamlin.
The FTSE 100 mining giant and commodity broker has struggled in recent times after being hit by a wave of investigations from regulators in the UK and the US over suspicions of alleged bribery, corruption and money laundering.
But in an act of faith in the company, Kamlin bought 500,000 shares on Tuesday at a price of 217p each, for a total transaction amount of £1.1m.
Another chief financial officer, Andrew Franklin of healthcare business Alliance Pharma (APH), cashed in shares this week in a deal worth just over £1m.
Franklin sold 1.37m shares at an average price of 76.9p each. Following the sale, Franklin retains 128,384 shares, equivalent to a 0.02% holding.
Alliance Pharma shares have been volatile this year, but in its last update to the market the firm saw strong growth in revenue and underlying profit.
Every Thursday, Shares will roundup the biggest director deals over the past week.
For a full list of the past week’s most significant director trades, click here.